X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5928) 5928
Book Review (509) 509
Publication (359) 359
Book Chapter (48) 48
Conference Proceeding (22) 22
Newsletter (22) 22
Government Document (4) 4
Data Set (2) 2
Dissertation (2) 2
Magazine Article (2) 2
Book / eBook (1) 1
Journal / eJournal (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5204) 5204
humans (3291) 3291
animals (2632) 2632
male (1763) 1763
collagenase (1604) 1604
female (1579) 1579
expression (1041) 1041
rats (950) 950
matrix metalloproteinases (918) 918
collagen (885) 885
middle aged (863) 863
mice (855) 855
adult (781) 781
iv collagenase (777) 777
cells, cultured (719) 719
collagenases - metabolism (706) 706
cell biology (690) 690
matrix metalloproteinase (652) 652
biochemistry & molecular biology (629) 629
aged (595) 595
inflammation (572) 572
tissue inhibitor (563) 563
abridged index medicus (516) 516
interstitial collagenase (485) 485
cells (482) 482
gene expression (472) 472
oncology (465) 465
immunohistochemistry (455) 455
proteins (443) 443
analysis (423) 423
activation (422) 422
immunology (421) 421
collagenases (418) 418
collagen - metabolism (417) 417
surgery (392) 392
enzymes (375) 375
extracellular-matrix (368) 368
research (367) 367
disease models, animal (365) 365
extracellular matrix (363) 363
multidisciplinary sciences (347) 347
fibroblasts (340) 340
cancer (332) 332
time factors (332) 332
matrix metalloproteinase 9 (331) 331
metalloproteinase (330) 330
gene-expression (328) 328
in-vitro (327) 327
angiogenesis (325) 325
metastasis (323) 323
cytokines (319) 319
research article (312) 312
microbial collagenase - metabolism (311) 311
rodents (307) 307
medicine (304) 304
enzyme-linked immunosorbent assay (298) 298
rats, sprague-dawley (298) 298
matrix metalloproteinase 9 - metabolism (296) 296
medicine, research & experimental (290) 290
physiological aspects (286) 286
neurosciences (261) 261
pathology (258) 258
article (248) 248
matrix metalloproteinases - metabolism (247) 247
peripheral vascular disease (247) 247
metalloendopeptidases - metabolism (246) 246
matrix metalloproteinase inhibitors (244) 244
rabbits (244) 244
collagenase 3 (242) 242
matrix metalloproteinase 2 - metabolism (240) 240
invasion (239) 239
hematology (237) 237
disease (234) 234
metalloproteinases (233) 233
pharmacology & pharmacy (233) 233
gelatinase (232) 232
collagenases - genetics (231) 231
science (230) 230
rheumatology (225) 225
physiology (224) 224
rna, messenger - metabolism (222) 222
blotting, western (219) 219
messenger-rna (219) 219
apoptosis (217) 217
cartilage (217) 217
dentistry (217) 217
molecular sequence data (216) 216
pregnancy (215) 215
aged, 80 and over (211) 211
osteoarthritis (211) 211
biochemistry (202) 202
arthritis (201) 201
degradation (201) 201
cattle (200) 200
inhibition (199) 199
matrix metalloproteinase 2 (193) 193
rheumatoid-arthritis (193) 193
gelatinases - metabolism (192) 192
mice, inbred c57bl (188) 188
proteases (188) 188
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5865) 5865
German (31) 31
Russian (23) 23
Japanese (21) 21
Polish (13) 13
Chinese (8) 8
French (7) 7
Korean (3) 3
Italian (2) 2
Spanish (2) 2
Ukrainian (2) 2
Czech (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cytokine, ISSN 1043-4666, 01/2013, Volume 61, Issue 1, pp. 315 - 322
► In adults and term infants, ventilation can lead to systemic inflammation. ► Systemic inflammation is associated with short-term ventilation in preterm... 
Chemokine | Ventilation | Inflammation | Preterm infant | Cytokine | BIOCHEMISTRY & MOLECULAR BIOLOGY | INJURY | BIRTH-WEIGHT | DEVELOPMENTAL DELAY | IMMUNOLOGY | RESPIRATORY-DISTRESS-SYNDROME | CHRONIC LUNG-DISEASE | CELL BIOLOGY | BRONCHOPULMONARY DYSPLASIA | GESTATION | BORN | T-CELLS | AGE | Chemokines - blood | Chorioamnionitis - blood | Infant, Premature, Diseases | Systemic Inflammatory Response Syndrome | Humans | Tumor Necrosis Factor-alpha - blood | Vascular Endothelial Growth Factor A - blood | Male | Chemokine CCL2 - blood | Inflammation - blood | Interleukin-1beta - blood | Chemokine CCL5 - blood | Pregnancy | Respiration, Artificial - adverse effects | Infant, Premature | Female | Infant, Extremely Premature | Intercellular Adhesion Molecule-1 - blood | Chemokine CCL4 - blood | Interleukin-8 - blood | Infant, Newborn | Cytokines - blood | Matrix Metalloproteinase 9 - blood | Infants (Premature) | Corticoids | Neonates | Chorioamnionitis | Cytokines | RANTES | Infants | Gestation | Matrix metalloproteinase | intercellular adhesion molecule 1 | Bacteremia | Blood | Gelatinase B | Models | Growth factors | Vascular endothelial growth factor | Chemokines | Injuries | Interleukin 8 | Interstitial collagenase | Monocyte chemoattractant protein 1 | Index Medicus | cytokine | chemokine | preterm infant | inflammation | ventilation
Journal Article
Journal Article
Stroke, ISSN 0039-2499, 09/2003, Volume 34, Issue 9, pp. 2165 - 2170
Journal Article
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 3/2018, Volume 55, Issue 3, pp. 2577 - 2590
After spinal cord injury (SCI), tight junction (TJ) protein degradation increases permeability and disrupts the blood–spinal cord barrier (BSCB). The BSCB is... 
Neurology | Neurosciences | Biomedicine | Tight junctions | Blood–spinal cord barrier | Neurobiology | Neuroinflammation | MMP-8 | Spinal cord injury | Cell Biology | Occludin | FUNCTIONAL RECOVERY | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | NEUTROPHIL INFILTRATION | VASCULAR EVENTS | NEUROSCIENCES | BRAIN-BARRIER | CELL JUNCTIONS | MESSENGER-RNA | Blood-spinal cord barrier | NITRIC-OXIDE | HEME OXYGENASE-1 | CEREBRAL-ISCHEMIA | Inflammation - pathology | Spinal Cord - drug effects | Spinal Cord - enzymology | Rats | Tight Junctions - enzymology | Blood-Brain Barrier - drug effects | Rats, Sprague-Dawley | Matrix Metalloproteinase Inhibitors - therapeutic use | Spinal Cord Injuries - pathology | Dose-Response Relationship, Drug | Spinal Cord Injuries - prevention & control | Blood-Brain Barrier - pathology | Matrix Metalloproteinase Inhibitors - pharmacology | Animals | Blood-Brain Barrier - enzymology | Spinal Cord Injuries - enzymology | Inflammation - drug therapy | Matrix Metalloproteinase 8 - metabolism | Spinal Cord - pathology | Female | Inflammation - enzymology | Tight Junctions - pathology | Disease Models, Animal | Tight Junctions - drug effects | Prevention | Immunohistochemistry | Cysteine | Proteolysis | Surgery | Nervous system | Spinal cord injuries | Inflammation | Permeability | Recombinant proteins | Endothelium | Compression | Matrix metalloproteinase | Blood | Western blotting | Degradation | Interleukin 6 | Proteins | Antioxidants | Cell activation | Extravasation | Rodents | Metalloproteinase | Neutrophils | Leukocytes (neutrophilic) | Tumor necrosis factor-α | Zonula occludens-1 protein | Nitric-oxide synthase | Endothelial cells | Cell injury | Sodium | Neutrophil collagenase | Protein expression | Infiltration | N-Acetyl-L-cysteine | Index Medicus
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 04/2017, Volume 16, Issue 1, pp. 55 - 55
Background: Altered regulation of extracellular matrix remodeling by matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) may... 
Tissue inhibitor of metalloproteinase | Cardiovascular disease | All-cause mortality | Matrix metalloproteinase | Type 1 diabetes | Estimated glomerular filtration rate | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | MYOCARDIAL-INFARCTION | HEART-FAILURE | MICROVASCULAR COMPLICATIONS | MELLITUS | EURODIAB PROSPECTIVE COMPLICATIONS | ENDOCRINOLOGY & METABOLISM | MATRIX-METALLOPROTEINASE-9 | TISSUE INHIBITOR | RETINOPATHY | DYSFUNCTION | Predictive Value of Tests | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Netherlands - epidemiology | Male | Cardiovascular Diseases - enzymology | Cause of Death | Incidence | Time Factors | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Adult | Female | Kidney - physiopathology | Cardiovascular Diseases - diagnosis | Tissue Inhibitor of Metalloproteinase-1 - blood | Diabetes Mellitus, Type 1 - enzymology | Glomerular Filtration Rate | Risk Assessment | Risk Factors | Proportional Hazards Models | Biomarkers - blood | Diabetes Mellitus, Type 1 - mortality | Diabetes Mellitus, Type 1 - diagnosis | Matrix Metalloproteinases, Secreted - blood | Diabetes Mellitus, Type 1 - blood | Matrix metalloproteinases | Epidermal growth factor receptors | Adjustment | Mortality | Diabetes mellitus | Health risks | Risk analysis | Tissue inhibitor of metalloproteinase 1 | Patients | Risk factors | Gelatinase A | Nephropathy | Extracellular matrix | Plasma levels | Blood pressure | Metalloproteinase | Cardiovascular diseases | Health risk assessment | Interstitial collagenase | Plasmas (physics) | Index Medicus
Journal Article
Scientific Reports, ISSN 2045-2322, 04/2017, Volume 7, Issue 1, pp. 46243 - 46243
As one of the most lethal stroke subtypes, intracerebral hemorrhage (ICH) is acknowledged as a serious clinical problem lacking effective treatment. Available... 
INTERLEUKIN-1 | SIGNALING PATHWAY | NEUROINFLAMMATION | EDEMA | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | BARRIER | RECEPTOR | GLYCATION END-PRODUCTS | SPONTANEOUS INTRACEREBRAL HEMORRHAGE | PROTECTS | Inflammation - pathology | Microglia - metabolism | Rats, Wistar | Apoptosis - drug effects | Brain Injuries - drug therapy | Motor Activity - drug effects | Antibodies, Monoclonal - therapeutic use | Male | Inflammation - blood | Cerebral Hemorrhage - blood | Inflammation - metabolism | Brain Edema - complications | Interleukin-1beta - metabolism | Brain Injuries - blood | Neurons - metabolism | Neurons - drug effects | HMGB1 Protein - antagonists & inhibitors | Astrocytes - drug effects | Permeability - drug effects | Microglia - drug effects | Antibodies, Monoclonal - pharmacology | Brain Edema - pathology | Vasoconstriction | Blood-Brain Barrier - drug effects | Blood-Brain Barrier - metabolism | Blood-Brain Barrier - pathology | Animals | Aquaporin 4 - metabolism | Brain Edema - drug therapy | Oxidative Stress - drug effects | Brain Injuries - etiology | Cerebral Hemorrhage - complications | Brain Edema - blood | HMGB1 Protein - blood | Astrocytes - metabolism | Edema | Oxidative stress | Stroke | Intravenous administration | Traumatic brain injury | Mobility | Collagenase | Inflammation | Injection | Hemorrhage | HMGB1 protein | Microglia | Neurological diseases | High mobility group proteins | DNA-binding protein | Blood-brain barrier | Collagen | Rodents | Neostriatum | Monoclonal antibodies | Brain injury | Index Medicus
Journal Article
Journal Article